Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

5.92
Delayed Data
As of Jun 30
 +0.24 / +4.23%
Today’s Change
5.06
Today|||52-Week Range
12.88
-36.95%
Year-to-Date

Today’s Trading

Previous close5.68
Today’s open5.66
Day’s range5.65 - 6.00
Volume2,021,562
Average volume (3 months)1,373,455
Market cap$247.3M
Dividend yield--
Data as of 4:00pm ET, 06/30/2015

Growth & Valuation

Earnings growth (last year)-32.86%
Earnings growth (this year)-34.05%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+43.45%
P/E ratioNM
Price/Sales2.92
Price/Book2.61

Competitors

 Today’s
change
Today’s
% change
ZGNXZogenix Inc+0.06+3.70%
NAVBNavidea Biopharmaceu...-0.02-1.23%
PPHMPeregrine Pharmaceut...+0.01+0.77%
CORICorium International...-0.14-1.01%
Data as of 4:06pm ET, 06/30/2015

Financials

Next reporting dateAugust 17, 2015
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$121.7M
Annual profit (last year)-$35.3M
Net profit margin-28.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers